Lunit

Founded in 2013, Lunit is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker analysis—empowering earlier detection, smarter treatment decisions, and more precise outcomes across the cancer care continuum.

Lunit offers a comprehensive suite spanning risk prediction and early detection to precision oncology. Our FDA-cleared Lunit INSIGHT Breast Suite and breast health solutions support cancer screening in thousands of medical institutions worldwide, while the Lunit SCOPE platform is used in research partnership with global pharma and laboratory leaders for biomarker research, and companion diagnostic development.

Trusted by over 10,000 sites in more than 65 countries, Lunit combines deep medical expertise with continuously evolving datasets to deliver measurable impact—for patients, clinicians, and researchers alike. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io/en.

Applications by this vendor

Lunit INSIGHT MMG

FDA, CE & Health Canada | FFDM

Lunit INSIGHT MMG (2D) mammography is a leading, globally trusted AI solution that supports earlier breast cancer detection, especially in dense breasts and interval cancers.

Lunit INSIGHT DBT

FDA, CE & Health Canada | DBT

Lunit INSIGHT® DBT is a leading, globally trusted AI-Powered Software for 3D Tomosynthesis that allows you to analyze multi-slice exams, highlight suspicious findings, speed up review, and reduce reading fatigue.